David D. Fuller, Ph.D

Physical Therapy University of Florida, Gainesville, Gainesville, FL, United States 
"David Fuller"
Mean distance: 19.38 (cluster 41)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Streeter KA, Sunshine MD, Brant JO, et al. (2019) Molecular and histologic outcomes following spinal cord injury in spiny mice, Acomys cahirinus. The Journal of Comparative Neurology
Sunshine MD, Ganji CN, Fuller DD, et al. (2019) Respiratory resetting elicited by single pulse spinal stimulation. Respiratory Physiology & Neurobiology. 103339
Doyle BM, Turner SMF, Sunshine MD, et al. (2019) AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice. Molecular Therapy. Methods & Clinical Development. 15: 194-203
Byrne BJ, Fuller DD, Smith BK, et al. (2019) Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy. Annals of Translational Medicine. 7: 290
Vemuri BC, Sun J, Banerjee M, et al. (2019) A geometric framework for ensemble average propagator reconstruction from diffusion MRI. Medical Image Analysis. 57: 89-105
Fields DP, Roberts BM, Simon AK, et al. (2018) Cancer cachexia impairs neural respiratory drive in hypoxia but not hypercapnia. Journal of Cachexia, Sarcopenia and Muscle
Cornelison RC, Gonzalez-Rothi E, Porvasnik SL, et al. (2018) Injectable hydrogels of optimized acellular nerve for injection in the injured spinal cord. Biomedical Materials (Bristol, England)
Sunshine MD, Ganji CN, Reier PJ, et al. (2018) Intraspinal microstimulation for respiratory muscle activation. Experimental Neurology
Turner S, Streeter K, Greer J, et al. (2017) Pharmacological modulation of hypoxia-induced respiratory neuroplasticity. Respiratory Physiology & Neurobiology
Corti M, Liberati C, Smith BK, et al. (2017) Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in children affected by Pompe Disease. Human Gene Therapy. Clinical Development
See more...